Kupando
Kupando developing TLR 4/7 agonists that stimulate innate immunity for use in oncology and infectious diseases.
Email Address
Founded Date
2018
Founder
Latest Funding Round Date
March 18, 2026
Latest Funding Round Amount (USD)
11,600,000
Latest Funding Type
LinkedIn URL
Location
Number of Employees (Ranges)
1 – 10
Total Funding Amount (USD)
11,600,000
Official Website
Find more companies like Kupando
Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
By using this site, you agree to our Terms of Service.